ALISO VIEJO, Calif., Nov. 17 /PRNewswire/ -- OCTANe hosted nearly 700 leading medical device industry executives from over 425 companies to discuss promising technology and emerging trends for the medical device industry last week at the 4th Annual CA Medical Device & Investor Forum.
“This panel of industry stars was an excellent foundation on which the rest of the conference was built,” said Matthew Jenusaitis, president and CEO of OCTANe. “The relationship between large companies, emerging growth companies, and the investment world is more important than ever, and this panel reflected OCTANe’s mission of stimulating the innovation ecosystem in our region.”
The lunch keynote spotlighted Healthcare Policy and Reform, and featured Christopher Cox, former SEC Chairman, as well as other leading DC experts. This discussion was followed by the keynote Investor Panel with Dr. Thomas Fogarty, a cardiovascular surgeon and world-renowned inventor, and leaders from New Leaf, Piper Jaffray, and De Novo Ventures.
About OCTANe:
OCTANe is fueling “innovation development” in Orange County and Southern California. By connecting people, capital and technology, OCTANe accelerates entrepreneurs and company development for Orange County’s biomedical and technology communities. The organization brings together the region’s leading biomedical and information technology companies, promising startups, entrepreneurs, venture capitalists, and universities to help create, grow, support, staff and fund innovative companies. For more information, visit www.octaneoc.org.
OCTANe
